MedPath
HSA Approval

TETRACYCLINE MC CAPSULE 250 mg

SIN00969P

TETRACYCLINE MC CAPSULE 250 mg

TETRACYCLINE MC CAPSULE 250 mg

May 10, 1988

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01AA07

tetracycline

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD - FACTORY AZ

Active Ingredients

TETRACYCLINE HCl EQV TETRACYCLINE

250 mg

Tetracycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.